The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

Cell

Volumn 98, Issue 2, 1999, Pages 137-146

  Sternlicht, Mark D ^a   Lochtest, Andre ^b   Sympson, Carolyn J ^b   Huey, Bing ^c   Rougier, Jean Philippe ^a   Gray, Joe W ^c   Pinkel, Dan ^c   Bissell, Mina J ^b   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; STROMELYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER RISK; CARCINOGENESIS; CELL IMMORTALIZATION; CELL SURFACE; ENZYME REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC STABILITY; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEREOTYPY; TRANSGENE;

EID: 0033597726     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81009-0     Document Type: Article

References (62)

1. Adolph, S., Bartram, C.R., and Hameister, H. (1987). Mapping of the oncogenes Myc, Sis, and int-1 to the distal part of mouse chromosome 15. Cytogenet. Cell Genet. 44, 65-68.
2. Ahmad, A., Hanby, A., Dublin, E., Poulsom, R., Smith, P., Barnes, D., Rubens, R., Anglard, P., and Hart, I. (1998). Stromelysin 3: an independent prognostic factorfor relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am. J. Pathol. 752, 721-728.
3. Alexander, C.M., Howard, E.W., Bissell, M.J., and Werb, Z. (1996). Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J. Cell Biol. 135, 1669-1677.
4. Bachman, K.E., Herman, J.G., Com, P.G., Merlo, A., Costello, J.F., Cavenee, W.K., Baylin, S.B., and Graft, J.R. (1999). Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers. Cancer Res. 59, 798-802.
5. Bain, G., Engel, I., Robanus Maandag, E.C., te Riele, H.P., Voland, J.R., Sharp, L.L., Chun, J., Huey, B., Pinkel, D., and Murre, C. (1997). E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 77,4782-4791.
6. Birchmeier, C., Birchmeier, W., and Brand-Saberi, B. (1996). Epithelial-mesenchymal transitions in cancer progression. Acta Anat. 156, 217-226.
7. Borsi, L., Carnemolla, B., Nicol, G., Spina, B., Tanara, G., and Zardi, L. (1992). Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer 52, 688-692.
8. Boudreau, N., Sympson, C.J., Werb, Z., and Bisseil, M.J. (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893.
9. Chin, J.R., and Werb, Z. (1997). Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 124, 1519-1530.
10. Christofori, G., and Semb, H. (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24, 73-76.
11. Coussens, L.M., and Werb, Z. (1996). Matrix metalloproteinases and the development of cancer. Chem. Biol. 3, 895-904.
12. D'Armiento, J., DiColandrea, T., Dalal, S.S., Okada, Y., Huang, M.T., Conney, A.H., and Chada, K. (1995). Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol. 15, 5732-5739.
13. DeOme, K.B., Faulkin, L.J.J., Bern, H.A., and Blair, P.E. (1959). Development of mammary tumors from hypeiplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 19, 515-520.
14. Domagala, W., Lasota, J., Bartkowiak, J., Weber, K., and Osborn, M. (1990). Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am. J. Pathol. 736, 219-227.
15. Donehower, L.A., Godley, LA., Aldaz, C.M., Pyle, R., Shi, Y.P., Pinkel, D., Gray, J., Bradley, A., Medina, D., and Varmus, H.E. (1995). Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9, 882-895.
16. Emmert-Buck, M.R., Bonner, R.F., Smith, P.D., Chuaqui, R.F., Zhuang, Z., Goldstein, S.R., Weiss, R.A., and Liotta, LA. (1996). Laser capture microdissection. Science 274, 998-1001.
17. Fisher, E.R., Gregorio, R.M., Fisher, B., Redmond, C., Vellios, F., and Sommers, S.C. (1975). The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 36, 1-85.
18. Fowlkes, J.L., Enghild, J.J., Suzuki, K., and Nagase, H. (1994). Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibreoblast cultures. J. Biol. Chem. 269, 25742-25746.
19. Gack, S., Vallon, R., Schaper, J., Ruther, U., and Angel, P. (1994). Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J. Biol. Chem. 269, 10363-10369.
20. Gilles, C., and Thompson, E.W. (1996). The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast J. 2, 83-96.
21. Hay, E.D. (1995). An overview of epithelio-mesenchymal transformation. Acta Anat. 154, 8-20.
22. Hirai, Y., Lochter A., Galosy, S., Koshida, S., Niwa, S., and Bissell, M.J. (1998). Epimorphin functions as a key morphoregulator for mammary epithelial cells. J. Cell Biol. 140, 159-169.
23. Howe, J.R., Roth, S., Ringold, J.C., Summers, R.W., Järvinen, H.J., Sistonen, P., Tomlinson, I.P., Houlston, R.S., Bevan, S., Mitros, F.A., et al. (1998). Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280, 1086-1088.
24. Hsieh, C.J., Klump, B., Holzmann, K., Borchard, F., Gregor, M., and Porschen, R. (1998). Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 58, 3942-3945.
25. Jacobs, T.W., Byrne, C., Colditz, G., Connolly, J.L., and Schnitt, S.J. (1999). Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N. Engl. J. Med. 340, 430-436.
26. Jacoby, R.F., Schlack, S., Cole, C.E., Skarbek, M., Harris, C., and Meisner, L F. (1997). A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology 112, 1398-1403.
27. Kataoka, H., Uchino, H., Iwamura, T., Seiki, M., Nabeshima, K., and Koono, M. (1999). Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of α-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. Am. J. Pathol. 154, 457-468.
28. Kim, K., Daniels, K.J., and Hay, E.D. (1998). Tissue-specific expression of β-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness. Exp. Cell Res. 245, 79-90.
29. Levi, E., Fridman, R., Miao, H.Q., Ma, Y.S., Yayon, A., and Vlodavsky, I. (1996). Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Natl. Acad. Sci. USA 93, 7069-7074.
30. Liu, M.L., Von Lintig, F.C., Liyanage, M., Shibata, M.A., Jorcyk, C.L., Ried, T., Boss, G.R., and Green, U.E. (1998). Amplification of Kiras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice. Oncogene 17, 2403-2411.
31. Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., and Bissell, M.J. (1997). Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139, 1861-1872.
32. Lochter, A., Muschler, J., Navre, M., Werb, Z., and Bissell, M.J. (1999). α1 and α2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol. Biol. Cell 10, 271-282.
33. Lukashev, M.E., and Werb, Z. (1998). ECM signaling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 8, 437-441.
34. Lund, L.R., Rømer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Danø, K., and Werb, Z. (1996). Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122, 181-193.
35. Martorana, A.M., Zheng, G., Crowe, T.C., O'Grady, R.L., and Lyons, J.G. (1998). Epithelial cells up-regulate matrix metalloproteinases in cells within the same mammary carcinoma that have undergone an epithelial-mesenchymal transition. Cancer Res. 58, 4970-4979.
36. Masson, R., Lefebvre, O., Noël, A., Fahime, M.E., Chenard, M.P., Wendung, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J.M., et al. (1998). In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140, 1535-1541.
37. Matrisian, L.M., Glaichenhaus, N., Gesnel, M.C., and Breathnach, R. (1985). Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EM BO J. 4, 1435-1440.
38. Mehindate, K., al-Daccak, R., Aoudjit, F., Damdoumi, F., Fortier, M., Borgeat, P., and Mourad, W. (1996). Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2. Lab. Invest. 75, 529-538.
39. Muller, D., Quantin, B., Gesnel, M.C., Millon-Collard, R., Abecassis, J., and Breathnach, R. (1988). The collagenase gene family in humans consists of at least four members. Biochem. J. 253, 187-192.
40. Noe, V., Willems, J., Vandekerckhove, J., Van Roy, F., Bruyneel, E., and Mareel, M. (1999). Inhibition of adhesion and induction of epithelial invasion by HAV-containing E-cadherin-specific peptides. J. Cell Sci. 112, 127-135.
41. Ostrowski, L.E., Finch, J., Krieg, P., Matrisian, L, Patskan, G., O'Connell, J.F., Phillips, J., Slaga, T.J., Breathnach, R., and Bowden, G.T. (1988). Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Mol. Carcinog. 1, 13-19.
42. Patterson, B.C., and Sang, Q.X.A. (1997). Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B type IV collagenase (MMP-9). J. Biol. Chem. 272, 28823-28825.
43. Ritland, S.R., Rowse, G.J., Chang, Y., and Gendler, S.J. (1997). Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice. Cancer Res. 57, 3520-3525.
44. Rønnov-Jessen, L, Petersen, O.W., and Bissell, M.J. (1996). Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76, 69-125.
45. Rudolph-Owen, L.A., Chan, R., Muller, W.J., and Matrisian, L.M. (1998). The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res. 58, 5500-5506.
46. Rutter, J.L, Mitchell, T.I., Butticè, G., Meyers, J., Gusella, J.F., Ozelius, L.J., and Brinckerhoff, C.E. (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58, 5321-5325.
47. Sommers, C.L., Byers, S.W., Thompson, E.W., Torri, J.A., and Gelmann, E.P. (1994). Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat. 31, 325-335.
48. Squartini, F., and Pingitore, R. (1994). Tumours of the mammary gland. In Pathology of Tumours in Laboratory Animals, V.S. Turusov and U. Mohr, eds. (Lyon, France: IARC Scientific Publications No. 111), pp. 47-100.
49. Sternlicht, M.D., and Werb, Z. (1999). ECM proteinases. In Guidebook to the Extracellular Matrix and Adhesion Proteins, T. Kreis and R. Vale, eds. (New York: Oxford University Press), pp. 503-562.
50. Sun, D., McAlmon, K.R., Davies, J.A., Bernfield, M., and Hay, E.D. (1998). Simultaneous loss of expression of syndecan-1 and E-cadherin inthe embryonic palate during epithelial-mesenchymal transformation. Int. J. Dev. Biol. 42, 733-736.
51. SundarRaj, N., Rizzo, J.D., Anderson, S.C., and Gesiotto, J.P. (1992). Expression of vimentin by rabbit corneal epithelial cells during wound repair. Cell Tissue Res. 267, 347-356.
52. Suzuki, M., Raab, G., Moses, M.A., Fernandez, C.A., and Klagsbrun, M. (1997). Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272, 31730-31737.
53. Sympson, C. J., Talhouk, R.S., Alexander, C.M., Chin, J.R., Clift, S.M., Bissell, M.J., and Werb, Z. (1994). Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125, 681-693. Erratum: J. Cell Biol. 732(4), 1996.
54. Talhouk, R.S., Bissell, M.J., and Werb, Z. (1992). Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118, 1271-1282.
55. Tetsu, O., and McCormick, F. (1999). β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
56. Thomasset, N., Lochter, A., Sympson, C.J., Lund, L.R., Williams, D.R., Behrendtsen, O., Werb, Z., and Bissell, M.J. (1998). Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am. J. Pathol. 153, 457-467.
57. Tlsty, T.D. (1998). Cell-adhesion-dependent influences on genomic instability and carcinogenesis. Curr. Opin. Cell Biol. 10, 647-653.
58. Wargotz, E.S., and Norris, H. J. (1989). Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum. Pathol. 20, 628-635.
59. Werb, Z. (1997). ECM and cell surface proteolysis: regulating cellular ecology. Cell 97, 439-442.
60. Wilson, C.L., Heppner, K.J., Labosky, P.A., Hogan, B.L, and Matrisian, L.M. (1997). Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA 94, 1402-1407.
61. Witty, J.P., Wright, J.H., and Matrisian, L.M. (1995). Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell 6, 1287-1303.
62. Ye, S., Eriksson, P., Hamsten, A., Kurkinen, M., Humphries, S.E., and Henney, A.M. (1996). Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 271, 13055-13060.